Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lipid Testing After Myocardial Infarction at the Montreal Heart Institute
Sponsor: Montreal Heart Institute
Summary
Because treatment decisions are usually based on a single measurement of the lipid panel at the time of an admission for an MI, the overarching objective of this project is to evaluate whether the measurement of LDL, non-HDL, and apoB values are reliable through all the duration of the hospitalization. It will be a single-center, prospective, observational study will be conducted, including consecutive patients hospitalized for myocardial infarction at the Montreal Heart Institute. Every patient at the Cardiac Care Unit will undergo non-fasting lipid panel testing at day 0 of their admission for Myocardial Infarction during the study period. Patients who consent to participate will have a 2nd non-fasting lipid panel drawn at day 2 of their admission. Thereafter, the levels of the different lipid values from the panel will be compared between day 0, day 2, and 4-6 weeks after discharge.
Official title: Timing of Lipid Testing During Hospitalization for MI and Subsequent Management of Dyslipidemia An Observational Study to Reduce the Care Gaps in Dyslipidemia in Canada
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2024-06-01
Completion Date
2026-05
Last Updated
2025-12-03
Healthy Volunteers
No
Interventions
Lipid panel
Lipid panel measuring levels of LDL, non-HDL and apoB
Locations (2)
Montreal Heart Institute
Montreal, Quebec, Canada
Montreal Heart Institute
Montreal, Quebec, Canada